Bcl-2 Gene Family and Related Proteins in Mammary Gland Involution and Breast Cancer

Journal of Mammary Gland Biology and Neoplasia

Volumn 4, Issue 2, 1999, Pages 153-164

  Schorr, Kristel ^a   Li, Minglin ^a   Krajewski, Stanislaw ^b   Reed, John C ^b   Furth, Priscilla A ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BURNHAM INSTITUTE   (United States)

^c IHV/MBC/UMB   (United States)

Author keywords

Apoptosis; Bcl 2 family; Breast cancer; Involution; Mammary gland

Indexed keywords

PROTEIN BCL 2;

ANIMAL; APOPTOSIS; BREAST; BREAST TUMOR; CELL SURVIVAL; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LACTATION; MOUSE; MULTIGENE FAMILY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PROGNOSIS; PROTO ONCOGENE; REVIEW; UDDER;

ANIMALS; APOPTOSIS; BREAST; BREAST NEOPLASMS; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION; GENES, BCL-2; HUMANS; LACTATION; MAMMARY GLANDS, ANIMAL; MICE; MULTIGENE FAMILY; PREGNANCY; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0033109102     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018773123899     Document Type: Article

References (92)

1. J. M. Adams and S. Cory (1998). The Bcl-2 protein family: Arbiters of cell survival. Science 281:1322-1326.
2. Y. Tsujimoto, L. R. Finger, J. Yunis, P. C. Nowell, and C. M. Croce (1984). Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226:1097-1099.
3. S. J. Korsmeyer (1992). Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879-886.
4. T. J. McDonnell and S. J. Korsmeyer (1991). Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18). Nature 349:254-256.
5. Z. N. Oltvai and S. J. Korsmeyer (1994). Checkpoints of dueling dimers foil death wishes [comment]. Cell 79:189-192.
6. G. T. Williams and C. A. Smith (1993). Molecular regulation of apoptosis: Genetic controls on cell death. Cell 74:777-779.
7. S. J. Korsmeyer (1995). Regulators of cell death. Trends Genet 11:101-105.
8. X. M. Yin, Z. N. Oltvai, and S. J. Korsmeyer (1994). BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax [see comments]. Nature 369:321-323.
9. T. Chittenden, C. Flemington, A. B. Houghton, R. G. Ebb, G. J. Gallo, B. Elangovan, G. Chinnadurai, and R. J. Lutz (1995). A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14:5589-5596.
10. D. T. Chao and S. J. Korsmeyer (1998). BCL-2 family: Regulators of cell death. Ann. Rev. Immunol. 16:395-419.
11. S. J. Korsmeyer, J. R. Shutter, D. J. Veis, D. E. Merry, and Z. N. Oltvai (1993). Bcl-2/Bax: A rheostat that regulates an anti-oxidant pathway and cell death. Semin. Cancer Biol. 4: 327-332.
12. W. Zhu, A. Cowie, G. W. Wasfy, L. Z. Penn, B. Leber, and D. W. Andrews (1996). Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types. EMBO J. 15:4130-4141.
13. H. Zha, H. A. Fisk, M. P. Yaffe, N. Mahajan, B. Herman, and J.:C. Reed (1996). Structure-function comparisons of the proapoptotic protein Bax in yeast and mammalian cells. Mol. Cell Biol. 16:6494-6508.
14. D. R. Green and J. C. Reed (1998). Mitochondria and apoptosis. Science 281:1309-1312.
15. J. C. Reed (1997). Double identity for proteins of the Bcl-2 family. Nature 387:773-776.
16. R. M. Kluck, E. Bossy-Wetzel, D. R. Green, and D. D. Newmeyer (1997). The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136.
17. J. Yang, X. Liu, K. Bhalla, C. N. Kim, A. M. Ibrado, J. Cai, T. I. Peng, D. P. Jones, and X. Wang (1997). Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275:1129-1132.
18. X. Liu, C. N. Kim, J. Yang, R. Jemmerson, and X. Wang (1996). Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86:147-157.
19. T. Rosse, R. Olivier, L. Monney, M. Rager, S. Conus, I. Fellay, B. Jansen, and C. Borner (1998). Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391: 496-499.
20. J. Zha, H. Harada, E. Yang, J. Jockel, and S. J. Korsmeyer (1996). Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87:619-628.
21. E. Yang, J. Zha, J. Jockel, L. H. Boise, C. B. Thompson, and S. J. Korsmeyer (1995). Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80:285-291.
22. S. Haldar, N. Jena, and C. M. Croce (1995). Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 92: 4507-4511.
23. S. Takayama, T. Sato, S. Krajewski, K. Kochel, S. Irie, J. A. Millan, and J. C. Reed (1995). Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity. Cell 80:279-284.
24. S. Takayama, D. N. Bimston, S. Matsuzawa, B. C. Freeman, C. Aime-Sempe, Z. Xie, R. I. Morimoto, and J. C. Reed (1997). BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J. 16:4887-4896.
25. G. Pan, K. O'Rourke, and V. M. Dixit (1998). Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J. Biol. Chem. 273: 5841-5845.
26. L. A. O'Reilly, D. C. Huang, and A. Strasser (1996). The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J. 15:6979-6990.
27. D. C. Huang, L. A. O'Reilly, A. Strasser, and S. Cory (1997). The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry. EMBO J. 16:4628-4638.
28. W. S. el-Deiry, J. W. Harper, P. M. O'Connor, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, and Y. Wang (1994). WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1169-1174.
29. C. Borner (1996). Diminished cell proliferation associated with the death-protective activity of Bcl-2. J. Biol. Chem. 271: 12695-12698.
30. E. J. Uhlmarm, C. D'Sa-Eipper, T. Subramanian, A. J. Wagner, N. Hay, and G. Chinnadurai (1996). Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: Suppression of apoptosis with concomitant cell proliferation. Cancer Res. 56:2506-2509.
31. G. Gil-Gomez, A. Berns, and H. J. Brady (1998). A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J. 17:7209-7218.
32. G. P. Linette, Y. Li, K. Roth, and S. J. Korsmeyer (1996). Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc. Natl. Acad. Sci. U.S.A. 93:9545-9552.
33. P. A. Furth, U. Bar-Peled, M. Li, A. Lewis, R. Laucerica, R. Jager, H. Weiher, and R. Russell (1999). Loss of anti-mitotic activity of Bcl-2 with retention of anti-apoptotic function during tumor progression in a mouse model. (Submitted).
34. K. L. Murphy, F. S. Kittrell, J. P. Gay, R. Jaeger, D. Medina, and J. M. Rosen (1999). Bcl-2 expression inhibits mammary tumor development in dimethylbenz(a) anthracene-treated transgenic mice. (Submitted).
35. R. C. Humphreys (1999). Programmed cell death in the terminal endbud. J. Mam. Gland Biol. Neoplasia 4:XXX-XXX
36. R. C. Humphreys, M. Krajewska, S. Krnacik, R. Jaeger, H. Weiher, S. Krajewski, J. C. Reed, and J.M. Rosen (1996). Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development 122:4013-4022.
37. K. Heermeier, M. Benedict, M. Li, P. Furth, G. Nunez, and L. Hennighausen (1996). Bax and Bcl-xs are induced at the onset of apoptosis in involuting mammary epithelial cells. Mech. Dev. 56:197-207.
38. S. Pullan, J. Wilson, A. Metcalfe, G. M. Edwards, N. Goberdhan, J. Tilly, J. A. Hickman, C. Dive, and C. H. Streuli (1996). Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J. Cell Sci. 109:631-642.
39. R. C. Bargou, P. T. Daniel, M. Y. Mapara, K. Bommert, C. Wagener, B. Kallinich, H. D. Royer, and B. Dorken (1995). Expression of the bcl-2 gene family in normal and malignant breast tissue: Low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Int. J. Cancer 60: 854-859.
40. J. M. Gee, J. F. Robertson, I. O. Ellis, P. Willsher, R. A. McClelland, H. B. Hoyle, S. R. Kyme, P. Finlay, R. W. Blamey, and R. I. Nicholson (1994). Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy. Int. J. Cancer 59:619-628.
41. G. J. Zhang, I. Kimijima, A. Tsuchiya, and R. Abe (1998). The role of bcl-2 expression in breast carcinomas (Review). Oncol. Rep. 5:1211-1216.
42. M. Li, J. Hu, K. Heermeier, L. Hennighausen, and P. A. Furth (1996). Expression of a viral oncoprotein during mammary gland development alters cell fate and function: Induction of p53-independent apoptosis is followed by impaired milk protein production in surviving cells. Cell Growth Differ. 7: 3-11.
43. M. Li, J. Hu, K. Heermeier, L. Hennighausen, and P. A. Furth (1996). Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways. Cell Growth Differ. 7:13-20.
44. A. Sierra, X. Castellsague, T. Coll, S. Manas, A. Escobedo, A. Moreno, and A. Fabra (1998). Expression of death-related genes and their relationship to loss of apoptosis in T1 ductal breast carcinomas. Int. J. Cancer 79:103-110.
45. S. Kitada, M. Krajewska, X. Zhang, D. Scudiero, J. M. Zapata, H. G. Wang, A. Shabaik, G. Tudor, S. Krajewski, T. G. Myers, G. S. Johnson, E. A. Sausville, and J. C. Reed (1998). Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines. Am. J. Pathol. 152:51-61.
46. J. M. Zapata, M. Krajewska, S. Krajewski, R. Huang, S. Takayama, H. G. Wang, E. Adamson, and J. C. Reed (1998). Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors. Breast Cancer Res. Treat. 47:129-140.
47. C. V. Clevenger, K. Thickman, W. Ngo, W. P. Chang, S. Takayama, and J. C. Reed (1997). Role of Bag-1 in the survival and proliferation of the cytokine-dependent lymphocyte lines, Ba/F3 and Nb2. Mol. Endocrinol. 11:608-618.
48. H. G. Wang, S. Takayama, U. R. Rapp, and J. C. Reed (1996). Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. U.S.A. 93:7063-7068.
49. S. Krajewski, M. Krajewska, A. Shabaik, H. G. Wang, S. Irie, L. Fong, and J. C. Reed (1994). Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res. 54: 5501-5507.
50. D. M. Hockenbery, M. Zutter, W. Hickey, M. Nahm, and S. J. Korsmeyer (1991). BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. U.S.A. 88:6961-6965.
51. S. Takayama, S. Krajewski, M. Krajewska, S. Kitada, J. M. Zapata, K. Kochel, D. Knee, D. Scudiero, G. Tudor, G. J. Miller, T. Miyashita, M. Yamada, and J. C. Reed (1998). Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res. 58:3116-3131.
52. S. Krajewski, M. Krajewska, A. Shabaik, T. Miyashita, H. G. Wang, and J. C. Reed (1994). Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am. J. Pathol. 145:1323-1336.
53. N. Motoyama, F. Wang, K. A. Roth, H. Sawa, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, and S. Fujii (1995). Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science 267:1506-1510.
54. A. Ma, J. C. Pena, B. Chang, E. Margosian, L. Davidson, F. W. Alt, and C. B. Thompson (1995). Bclx regulates the survival of double-positive thymocytes. Proc. Natl. Acad. Sci. U.S.A. 92:4763-4767.
55. S. Kamada, A. Shimono, Y. Shinto, T. Tsujimura, T. Takahashi, T. Noda, Y. Kitamura, H. Kondoh, and Y. Tsujimoto (1995). Bcl-2 deficiency in mice leads to pleiotropic abnormalities: Accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res. 55:354-359.
56. D. J. Veis, C. M. Sorenson, J. R. Shutter, and S. J. Korsmeyer (1993). Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-240.
57. V. S. Ratts, J. A. Flaws, R. Kolp, C. M. Sorenson, and J. L. Tilly (1995). Ablation of bcl-2 gene expression decreases the numbers of oocytes and primordial follicles established in the post-natal female mouse gonad. Endocrinology 136: 3665-3668.
58. T. M. Michaelidis, M. Sendtner, J. D. Cooper, M. S. Airaksinen, B. Holtmann, M. Meyer, and H. Thoenen (1996). Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron 17:75-89.
59. K. Nakayama, I. Negishi, K. Kuida, H. Sawa, and D. Y. Loh (1994). Targeted disruption of Bcl-2 alpha beta in mice: Occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Natl. Acad. Sci. U.S.A. 91:3700-3704.
60. K. Nakayama, I. Negishi, K. Kuida, Y. Shinkai, M. C. Louie, L. E. Fields, P. J. Lucas, V. Stewart, and F. W. Alt (1993). Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 261:1584-1588.
61. T. L. Deckwerth, J. L. Elliott, C. M. Knudson, E. M. Johnson, Jr., W. D. Snider, and S. J. Korsmeyer (1996). BAX is required for neuronal death after trophic factor deprivation and during development. Neuron 17:401-411.
62. F. A. White, C. R. Keller-Peck, C. M. Knudson, S. J. Korsmeyer, and W. D. Snider (1998). Widespread elimination of naturally occurring neuronal death in Bax-deficient mice. J. Neurosci. 18:1428-1439.
63. C. M. Knudson, K. S. Tung, W. G. Tourtellotte, G. A. Brown, and S. J. Korsmeyer (1995). Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270: 96-99.
64. C. G. Print, K. L. Loveland, L. Gibson, T. Meehan, A. Stylianou, N. Wreford, D. de Kretser, D. Metcalf, F. Kontgen, J. M. Adams, and S. Cory (1998). Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant [In process citation]. Proc. Natl. Acad. Sci. U.S.A. 95: 12424-12431.
65. A. J. Ross, K. G. Waymire, J. E. Moss, A. F. Parlow, M. K. Skinner, L. D. Russell, and G. R. MacGregor (1998). Testicular degeneration in Bclw-deficient mice [see comments]. Nat. Genet. 18:251-256.
66. K. Schorr, U. Bar-Peled, M. Li, A. Lewis, A. Heredia, B. Lewis, C. M. Knudson, S. J. Korsmeyer, R. Jager, H. Weiher, and P. A. Furth, (1999). Gain of Bcl-2 is more potent than Bax loss in regulating mammary epithelial cell survival during tissue remodeling, Cancer Research: (in press).
67. K. U. Wagner, R. J. Wall, L. St-Onge, P. Gruss, A. Wynshaw-Boris, L. Garrett, M. Li, P. A. Furth, and L. Hennighausen (1997). Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 25:4323-4330.
68. J. Rodriguez-Villanueva, D. Greenhalgh, X. J. Wang, D. Bundman, S. Cho, M. Delehedde, D. Roop, and T. J. McDonnell (1998). Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation. Oncogene 16:853-863.
69. P. Naik, J. Karrim, and D. Hanahan (1996). The rise and fall of apoptosis during multistage tumorigenesis: Down-modulation contributes to tumor progression from angiogenic progenitors. Genes Dev. 10:2105-2116.
70. R. Jager, U. Herzer, J. Schenkel, and H. Weiher (1997). Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Oncogene 15: 1787-1795.
71. C. Teixeira, J. C. Reed, and M. A. Pratt (1995). Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 55:3902-3907.
72. T. T. Wang and J. M. Phang (1995). Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res. 55:2487-2489.
73. Y. Huang, S. Ray, J. C. Reed, A. M. Ibrado, C. Tang, A. Nawabi, and K. Bhalla (1997). Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res. Treat. 42:73-81.
74. D. Delia, A. Aiello, D. Soligo, E. Fontanella, C. Melani, F. Pezzella, M. A. Pierotti, and G. Della Porta (1992). bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79:1291-1298.
75. J. C. Reed (1996). Balancing cell life and death: Bax, apoptosis, and breast cancer [editorial; comment]. J. Clin. Invest. 97: 2403-2404.
76. J. C. Reed (1994). Bcl-2 and the regulation of programmed cell death. J. Cell. Biol. 124:1-6.
77. S. Krajewski, C. Blomqvist, K. Franssila, M. Krajewska, V. M. Wasenius, E. Niskanen, S. Nordling, and J.C. Reed (1995). Reduced expression of proapoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 55:4471-4478.
78. A. Marti, Z. Feng, B. Jehn, V. Djonov, G. Chicaiza, H. J. Altermatt, and R. Jaggi (1995). Expression and activity of cell cycle regulators during proliferation and programmed cell death in the mammary gland. Cell Death Differ 2:277-284.
79. P. Lipponen, T. Pietilainen, V. M. Kosma, S. Aaltomaa, M. Eskelinen, and K. Syrjanen (1995). Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favorable prognosis. J. Pathol. 177:49-55.
80. S. W. Lowe, H. E. Ruley, T. Jacks, and D. E. Housman (1993). p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967.
81. L. R. Lund, J. Romer, N. Thomasset, H. Solberg, C. Pyke, M. J. Bissell, K. Dano, and Z. Werb (1996). Two distinct phases of apoptosis in mammary gland involution: Proteinase-independent and -dependent pathways. Development 122: 181-193.
82. R. C. Bargou, C. Wagener, K. Bommert, M. Y. Mapara, P. T. Daniel, W. Arnold, M. Dietel, H. Guski, A. Feller, H. D. Royer, and B. Dorken (1996). Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice [see comments]. J. Clin. Invest. 97:2651-2659.
83. C. M. Knudson and S. J. Korsmeyer (1997). Bcl-2 and Bax function independently to regulate cell death. Nat. Genet. 16:358-363.
84. C. Yin, C. M. Knudson, S. J. Korsmeyer, and T. Van Dyke (1997). Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385:637-640.
85. R. Bernard, S. Dieni, S. Rees, and O. Bernard (1998). Physiological and induced neuronal death are not affected in NSE-bax transgenic mice. J. Neurosci. Res. 52:247-259.
86. P. G. Farlie, R. Dringen, S. M. Rees, G. Kannourakis, and O. Bernard (1995). bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc. Natl. Acad. Sci. U.S.A. 92:4397-4401.
87. J. C. Martinou, M. Dubois-Dauphin, J. K. Staple, I. Rodriguez, H. Frankowski, M. Missotten, P. Albertini, D. Talabot, S. Catsicas, and C. Pietra (1994). Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13:1017-1030.
88. M. Dubois-Dauphin, H. Frankowski, Y. Tsujimoto, J. Huarte, and J. C. Martinou (1994). Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc. Natl. Acad. Sci. U.S.A. 91:3309-3313.
89. D. A. Grillot, R. Merino, J. C. Pena, W. C. Fanslow, F. D. Finkelman, C. B. Thompson, and G. Nunez (1996). Bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J. Exp. Med. 183:381-391.
90. D. A. Grillot, R. Merino, and G. Nunez (1995).Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion intransgenic mice. J. Exp. Med. 182:1973-1983.
91. J. C. Reed, S. Krajewski, S. Kitada, and T. Miyashita (1998) Methods of measuring Bcl-2 gene expression. In Handbook of Experimental Immunology, Ed. Herzenberg and Weir Blackwell Science, Cambridge.
92. S. Krajewski, A. Hugger, M. Krajewska, J. C. Reed, and J. K. Mai (1998). Developmental expression patterns of Bcl-2, Bcl-x, Bax, and Bak in teeth. Cell Death Differ. 5: 408-415.